182 related articles for article (PubMed ID: 30980394)
1. Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013.
Shiels MS; Engels EA; Yanik EL; McGlynn KA; Pfeiffer RM; O'Brien TR
Cancer; 2019 Aug; 125(15):2621-2630. PubMed ID: 30980394
[TBL] [Abstract][Full Text] [Related]
2. Death certificates compared to SEER-Medicare data for surveillance of liver cancer mortality due to hepatitis B or hepatitis C infection.
Jiang JJ; Shiels MS; O'Brien TR
J Viral Hepat; 2021 Jun; 28(6):934-941. PubMed ID: 33720473
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study.
Davila JA; Morgan RO; Shaib Y; McGlynn KA; El-Serag HB
Gastroenterology; 2004 Nov; 127(5):1372-80. PubMed ID: 15521006
[TBL] [Abstract][Full Text] [Related]
4. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
[TBL] [Abstract][Full Text] [Related]
5. Population attributable fractions of risk factors for hepatocellular carcinoma in the United States.
Makarova-Rusher OV; Altekruse SF; McNeel TS; Ulahannan S; Duffy AG; Graubard BI; Greten TF; McGlynn KA
Cancer; 2016 Jun; 122(11):1757-65. PubMed ID: 26998818
[TBL] [Abstract][Full Text] [Related]
6. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
[TBL] [Abstract][Full Text] [Related]
7. Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma.
Golabi P; Jeffers T; Younoszai Z; Otgonsuren M; Sayiner M; Mishra A; Venkatesan C; Younossi ZM
Ann Hepatol; 2017; 16(4):555-564. PubMed ID: 28611258
[TBL] [Abstract][Full Text] [Related]
8. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
9. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level.
Yates SC; Hafez M; Beld M; Lukashov VV; Hassan Z; Carboni G; Khaled H; McMorrow M; Attia M; Goudsmit J
Am J Trop Med Hyg; 1999 Apr; 60(4):714-20. PubMed ID: 10348253
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma - United States, 2001-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(17):517-20. PubMed ID: 20448528
[TBL] [Abstract][Full Text] [Related]
12. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.
Welzel TM; Graubard BI; Quraishi S; Zeuzem S; Davila JA; El-Serag HB; McGlynn KA
Am J Gastroenterol; 2013 Aug; 108(8):1314-21. PubMed ID: 23752878
[TBL] [Abstract][Full Text] [Related]
13. Burden of virus-associated liver cancer in the Arab world, 1990-2010.
Khan G; Hashim MJ
Asian Pac J Cancer Prev; 2015; 16(1):265-70. PubMed ID: 25640363
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.
Makarova M; Krettek A; Valkov MY; Grjibovski AM
Int J Circumpolar Health; 2013; 72():20282. PubMed ID: 23687637
[TBL] [Abstract][Full Text] [Related]
15. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.
Kirk GD; Lesi OA; Mendy M; Akano AO; Sam O; Goedert JJ; Hainaut P; Hall AJ; Whittle H; Montesano R
Hepatology; 2004 Jan; 39(1):211-9. PubMed ID: 14752840
[TBL] [Abstract][Full Text] [Related]
16. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
17. Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.
Sinn DH; Gwak GY; Cho J; Paik SW; Yoo BC
PLoS One; 2014; 9(11):e112184. PubMed ID: 25372403
[TBL] [Abstract][Full Text] [Related]
18. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.
Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
J Viral Hepat; 2022 May; 29(5):352-365. PubMed ID: 35274406
[TBL] [Abstract][Full Text] [Related]
19. Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).
Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ
J Hepatol; 2016 Dec; 65(6):1086-1093. PubMed ID: 27569777
[TBL] [Abstract][Full Text] [Related]
20. Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.
Hernandez BY; Zhu X; Kwee S; Chan OT; Tsai N; Okimoto G; Horio D; McGlynn KA; Altekruse S; Wong LL
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2016-23. PubMed ID: 23983238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
